tiprankstipranks

BIOTECH TARGET N V Insider Profile

11 Followers
BIOTECH TARGET N V, Ten Percent Owner at Cidara Therapeutics, holds 0.00 shares in Molecular Templates (Ticker: MTEM), holds 9.93M shares in MacroGenics (Ticker: MGNX), holds 8.73M shares in Radius Health (Ticker: ~RDUS). Most recently, BIOTECH TARGET N V Sold ― shares of Molecular Templates on Nov 18, 2024 for an estimated value of 844.68K.
tipranks
BIOTECH TARGET N V

BIOTECH TARGET N V
Cidara Therapeutics (CDTX)
Ten Percent Owner

Ranked #96,946 out of 99,635 Corporate Insiders

Profitable Transactions

32%
19 out of 60 Profitable Transactions

Average Return

-29.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$87M
49.27%
37.52%
13.22%
0.00%
A breakdown of BIOTECH TARGET N V's holdings

Insider Roles

Cidara Therapeutics
(CDTX)
Ten Percent Owner
MacroGenics
(MGNX)
Ten Percent Owner
Esperion
(ESPR)
Ten Percent Owner
Molecular Templates
(MTEM)
Ten Percent Owner
Roles that BIOTECH TARGET N V holds in companies

Most Profitable Insider Trade

Stock:
MacroGenics
(MGNX)
Rating:Informative Buy
Date:Feb 16, 2023 - Feb 16, 2024
Return:+228.50%
The most profitable trade made by BIOTECH TARGET N V

BIOTECH TARGET N V's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Cidara Therapeutics
Nov 16, 2017
Ten Percent Owner
Informative Buy
453.60K
$42.90M
Esperion
May 26, 2021
Ten Percent Owner
Informative Buy
2.02M
$11.51M
~RDUS
Radius Health
May 20, 2022
Informative Buy
2.66M
$88.03M
Molecular Templates
Nov 18, 2024
Ten Percent Owner
Informative Sell
844.68K
$0.00
MacroGenics
Oct 04, 2023
Ten Percent Owner
Informative Buy
669.00K
$32.67M
List of latest transactions for each holding click on a transaction to see BIOTECH TARGET N V's performance on stock

BIOTECH TARGET N V insider profile FAQ

What is the percentage of profitable transactions made by BIOTECH TARGET N V?
The percentage of profitable transactions made by BIOTECH TARGET N V is 32%.
    What is the average return per transaction made by BIOTECH TARGET N V?
    The average return per transaction made by BIOTECH TARGET N V is -29.50%.
      What stocks does BIOTECH TARGET N V hold?
      BIOTECH TARGET N V holds: CDTX, ESPR, ~RDUS, MTEM, MGNX stocks.
        What was BIOTECH TARGET N V’s latest transaction?
        BIOTECH TARGET N V latest transaction was an Informative Sell of $844.68K.
          What was BIOTECH TARGET N V's most profitable transaction?
          BIOTECH TARGET N V’s most profitable transaction was an Informative Buy of MGNX stock on February 16, 2023. The return on the trade was 228.50%.
            What is BIOTECH TARGET N V's role in Cidara Therapeutics?
            BIOTECH TARGET N V's role in Cidara Therapeutics is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.